Safety Study of Abatacept to Treat Refractory Sarcoidosis (STAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00739960
Recruitment Status : Terminated (Funding has been pulled)
First Posted : August 22, 2008
Last Update Posted : June 11, 2013
Bristol-Myers Squibb
Information provided by (Responsible Party):
University of Chicago

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : December 2008
  Study Completion Date : December 2008

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 November 19, 2015 December 23, 2015